Pfizer recognizes that this is a critical time for planning around COVID-19 vaccination efforts. As such, Pfizer is committed to sharing important updates.
The Pfizer-BioNTech COVID-19 Vaccine website for US healthcare professionals is now available at www.cvdvaccine.com.
Pfizer will be hosting a series of training sessions to review information and answer questions on storage, handling, and administration. Please use the links below to join the sessions at the designated times.
Don’t Miss this CDC Webinar on Dec. 18
|Date & Time||Password|
|December 15, 2020 5:00 PM ET||cXQqYzTM352|
|December 16, 2020 10:00 AM ET||yDxuqt6Pg52|
|December 16, 2020 5:00 PM ET||auKMUdmJ687|
|December 17, 2020 10:00 AM ET||TMr7GvMc2P2|
|December 17, 2020 5:00 PM ET||PPxyyuGP249|
|December 18, 2020 10:00 AM ET||GawpMXB2X95|
|December 18, 2020 5:00 PM ET||w3kBrP9ReU3|
If you have any questions: you may contact Pfizer at https://www.pfizer.com/contact.
The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by FDA, but has been authorized for emergency use by FDA under an Emergency Use Authorization to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.
Please see Emergency Use Authorization (EUA) Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) including Full EUA Prescribing Information available at www.cvdvaccine.com.